Tata Nifty MidSmall Healthcare Index Fund - IDCW - Regular Plan

Other Plans and Options
  • (-0.77%)Nav, as on 18-07-2025

  • Previous Nav

  • Net Change on 18-07-2025

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview IDCW | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The investment objective of the scheme is to provide returns, before expenses, that are in line with the performance of Nifty MidSmall Healthcare Index (TRI), subject to tracking error.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
NIFTY 50 - TRI N/A N/A N/A N/A N/A N/A
Nifty MidSmall Healthcare - TRI N/A N/A N/A N/A N/A N/A

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
DSP Nifty 50 Equal Weight Index Fund - Regular Plan - IDCW Oct 23, 2017 0.09 19.29 23.59 0.05 2,226.58
Axis Nifty 100 Index Fund - Regular Plan - IDCW Oct 18, 2019 -0.37 15.80 18.34 0.92 1,948.53
Sundaram Nifty 100 Equal Weight Fund (Formerly Known as Principal Nifty 100 Equal Weight Fund-Income Distribution CUM Capital Withdrawal Mar 09, 2004 -2.61 19.05 21.73 1.08 110.05

Fund Holdings as on 30-June-2025

  • MAX HEALTHCARE INSTITUTE LTD.

  • LUPIN LTD.

  • FORTIS HEALTHCARE LTD.

  • AUROBINDO PHARMA LTD.

  • LAURUS LABS LTD.

  • ALKEM LABORATORIES LTD.

  • GLENMARK PHARMACEUTICALS LTD.

  • MANKIND PHARMA LTD

  • BIOCON LTD.

  • IPCA LABORATORIES LTD.

  • ABBOTT INDIA LTD.

  • KRISHNA INSTITUTE OF MEDICAL SCIENCES LTD.

  • NARAYANA HRUDAYALAYA LTD.

  • GLAND PHARMA LTD.

  • GLAXOSMITHKLINE PHARMACEUTICALS LTD.

  • J.B.CHEMICALS & PHARMACEUTICALS LTD.

  • ASTER DM HEALTHCARE LTD.

  • PIRAMAL PHARMA LTD

  • COHANCE LIFESCIENCES LTD.

  • SYNGENE INTERNATIONAL LTD.

  • AJANTA PHARMA LTD.

  • DR. LAL PATH LABS LTD.

  • NEULAND LABORATORIES LTD.

  • GLOBAL HEALTH LTD.

  • PFIZER LTD.

  • POLY MEDICURE LTD.

  • NATCO PHARMA LTD.

  • RAINBOW CHILDRENS MEDICARE LTD.

  • GRANULES INDIA LTD.

  • ALEMBIC PHARMACEUTICALS LTD.

  • A) REPO

  • NET CURRENT LIABILITIES

View More

  • Pharmaceuticals & Drugs

  • Hospital & Healthcare Services

  • Business Support

  • Medical Equipment/Supplies/Accessories

  • Miscellaneous

View More

Fund Manager

  • Cash

  • Equity

View More

About Tata Nifty MidSmall Healthcare Index Fund

Scheme Analysis

Tata Nifty MidSmall Healthcare Index Fund is a Index Funds - Other fund and belongs to Tata Mutual Fund. It was launched on 26-Apr-2024 and currently has an AUM of ₹147.99 crore. Tata Nifty MidSmall Healthcare Index Fund is benchmarked against NIFTY 50 - TRI as primary index and Nifty MidSmall Healthcare - TRI as secondary index.

The NAV of Tata Nifty MidSmall Healthcare Index Fund ended down ₹-0.1(-0.77%)yesterday to ₹13.1474.

Among its top 3 holdings the fund has exposure to MAX HEALTHCARE INSTITUTE LTD., and

The Tata Nifty MidSmall Healthcare Index Fund is managed by Rakesh Prajapati and Nitin Sharma.

Fund House Contact

1903, B Wing, Parinee Crescenzo, G Block, Bandra Kurla Complex, Bandra East, Mumbai - 400 051

022 6282 7777
service@tataamc.com
+91 (22) 22613782